[go: up one dir, main page]

AU4675300A - Recombinant laminin 5 - Google Patents

Recombinant laminin 5

Info

Publication number
AU4675300A
AU4675300A AU46753/00A AU4675300A AU4675300A AU 4675300 A AU4675300 A AU 4675300A AU 46753/00 A AU46753/00 A AU 46753/00A AU 4675300 A AU4675300 A AU 4675300A AU 4675300 A AU4675300 A AU 4675300A
Authority
AU
Australia
Prior art keywords
recombinant laminin
laminin
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46753/00A
Inventor
Ariel Boutaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOSTATUM Inc
Original Assignee
BIOSTATUM Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOSTATUM Inc filed Critical BIOSTATUM Inc
Publication of AU4675300A publication Critical patent/AU4675300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
AU46753/00A 1999-04-30 2000-04-28 Recombinant laminin 5 Abandoned AU4675300A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13172099P 1999-04-30 1999-04-30
US60131720 1999-04-30
US14973899P 1999-08-21 1999-08-21
US60149738 1999-08-21
US15594599P 1999-09-24 1999-09-24
US60155945 1999-09-24
PCT/US2000/011459 WO2000066731A2 (en) 1999-04-30 2000-04-28 Recombinant laminin 5

Publications (1)

Publication Number Publication Date
AU4675300A true AU4675300A (en) 2000-11-17

Family

ID=27384196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46753/00A Abandoned AU4675300A (en) 1999-04-30 2000-04-28 Recombinant laminin 5

Country Status (4)

Country Link
EP (1) EP1177290A2 (en)
JP (1) JP2002542824A (en)
AU (1) AU4675300A (en)
WO (1) WO2000066731A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933273B2 (en) 2000-12-21 2005-08-23 Karl Tryggvason Isolated laminin 10
JP4798560B2 (en) * 2003-06-04 2011-10-19 よこはまティーエルオー株式会社 Laminin 5B
JP4566603B2 (en) * 2004-03-31 2010-10-20 財団法人かずさディー・エヌ・エー研究所 Cell attachment polypeptide
FR2873698B1 (en) * 2004-07-29 2006-10-20 D Anjou Sa Lab NEW PEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
US20060210603A1 (en) * 2005-02-23 2006-09-21 Williams Stuart K Implantable medical articles having laminin coatings and methods of use
FR2943062B1 (en) * 2009-03-13 2011-04-08 Symatese NEW PEPTIDE PROMOTING CELL ADHESION AND MIGRATION
JP6470286B2 (en) 2013-11-27 2019-02-13 京都府公立大学法人 Application of laminin to corneal endothelial cell culture
WO2016067628A1 (en) 2014-10-31 2016-05-06 京都府公立大学法人 Novel treatment of cornea using laminin
JP6770435B2 (en) 2014-10-31 2020-10-14 京都府公立大学法人 New treatment of retinal and nerve with laminin
JP6792852B2 (en) * 2016-06-07 2020-12-02 国立大学法人 岡山大学 Keratinized gingival inducer
AU2018262323A1 (en) * 2017-05-05 2019-11-21 National University Of Singapore Methods for culturing human keratinocytes
FR3127219B1 (en) 2021-09-20 2025-04-11 Laboratoires Danjou NEW PEPTIDES AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINERS THEREOF

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8802441A1 (en) * 1985-06-03 1988-06-16 Meloy Lab Laminin and the production thereof.
DE69330352T2 (en) * 1992-08-28 2002-01-03 State Of Oregon By And Through The Oregon State Board Of Higher Education For And On Behalf Of The Oregon, Portland AGENTS AND METHODS FOR IMPROVING KERATINOCYTEN ADHESION TO THE SKIN
US5422264A (en) * 1993-11-12 1995-06-06 Desmos, Inc. Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells
US5610031A (en) * 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5660982A (en) * 1994-10-04 1997-08-26 Tryggvason; Karl Laminin chains: diagnostic uses
US5681587A (en) * 1995-10-06 1997-10-28 Desmos, Inc. Growth of adult pancreatic islet cells
WO1997036621A1 (en) * 1996-03-29 1997-10-09 Desmos, Inc. Cellular attachment to laminin 5-coated trans-epithelial appliances
WO1997048415A1 (en) * 1996-06-05 1997-12-24 The General Hospital Corporation Laminin-5 and the formation of basement membrane structure
US5760179A (en) * 1996-06-10 1998-06-02 Desmos, Inc. Purification of soluble laminin 5
AU4220797A (en) * 1996-09-13 1998-04-02 Protegene Inc. Human proteins having secretory signal sequences and DNAs encoding these prot eins

Also Published As

Publication number Publication date
WO2000066731A2 (en) 2000-11-09
EP1177290A2 (en) 2002-02-06
WO2000066731A3 (en) 2001-06-28
JP2002542824A (en) 2002-12-17

Similar Documents

Publication Publication Date Title
GB9923177D0 (en) Novel polypeptide
AU4675300A (en) Recombinant laminin 5
AU5706000A (en) Useful polypeptide
AU2691500A (en) Novel polypeptide
AU6277699A (en) Guarantee 20
GB9923889D0 (en) Novel polypeptide
AU4778600A (en) Novel polypeptide
GB9924951D0 (en) Novel polypeptide
AU2109200A (en) Polypeptide
GB9923893D0 (en) Novel polypeptide
GB9923890D0 (en) Novel polypeptide
AU6712600A (en) Polypeptides
AU1228201A (en) Umlr polypeptides
AU6637700A (en) Tryptase-like polypeptide ztryp1
AU2341501A (en) A novel peptide--gammal1-pyrroline-5-hydroxy-reductase 14 and the polynucleotidecoding this novel peptide
GB9924960D0 (en) Novel polypeptide
GB9925115D0 (en) Novel polypeptide
GB9923888D0 (en) Novel polypeptide
GB9924956D0 (en) Novel polypeptide
AU1316201A (en) Polypeptide composition
AUPP900899A0 (en) Novel peptides
AUPP841999A0 (en) Novel peptides
AUPQ305799A0 (en) Peptides
AUPQ387399A0 (en) Peptides
AUPQ404699A0 (en) Project 4

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase